🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The study is a placebo-controlled, double-blind, randomized, phase 3 study ...
Status
Completed
Location
East Valley Diabetes & Endocrinology
Start Date
2024-03-01
Trial ID
NCT06005597
This study will be a placebo-controlled, double-blind, randomized, phase 2 ...
Status
Completed
Location
Pinnacle Research Group
Start Date
2021-02-18
Trial ID
NCT04753606
Treatments Being Tested
This study will be a placebo-controlled, double-blind, randomized, phase 3 ...
Status
Active Not Recruiting
Location
Advanced Cardiovascular LLC
Start Date
2022-02-07
Trial ID
NCT05202509
Treatments Being Tested
The goal of this clinical trial is to learn if Obicetrapib works to change ...
Status
Recruiting
Location
Excellence Medical Research
Start Date
2025-09-09
Trial ID
NCT06982508
Treatments Being Tested
This Phase 3, randomized, double-blind, active-controlled study evaluates t...
Status
Recruiting
Location
FutureMeds North Tees
Start Date
2026-05-06
Trial ID
NCT07614958
Treatments Being Tested
This study will assess the effect of food on the bioavailability of obicetr...
Status
Completed
Location
NOVUM
Start Date
2024-01-20
Trial ID
NCT06050291
Treatments Being Tested
A study to evaluate the impact of Obicetrapib on the PK levels of Drospiren...
Status
Completed
Location
NOVUM
Start Date
2024-02-05
Trial ID
NCT06250205
To investigate the safety and pharmacokinetics in patients with moderate he...
Status
Completed
Location
Nucleus Network
Start Date
2023-11-30
Trial ID
NCT06048302
Treatments Being Tested
This study will be a placebo-controlled, double-blind, randomized, phase 2 ...
Status
Completed
Location
Nippon Kokan Fukuyama Hospital
Start Date
2022-06-27
Trial ID
NCT05421078
Treatments Being Tested
A study to evaluate impact of Obicetrapib on PK levels of Atorvastatin and ...
Status
Completed
Location
Mark M Feldman
Start Date
2023-11-11
Trial ID
NCT06081166
Treatments Being Tested